CD109 exhibits a dynamic expression pattern in coronary endothelium and endocardial-derived valve mesenchyme during heart development with preserved morphogenesis following endothelial-specific deletion
Open Access
- 19 June 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1867997
Abstract
Background: CD109 encodes a GPI-linked glycoprotein that acts as a signaling modulator in the TGF-β pathway. CD109 has emerged in several genome-wide association studies as linked to coronary artery disease, myocardial infarction, and angina pectoris. Heterozygous loss-of-function mutations in CD109 have also been reported in patients with congenital heart defects, suggesting potential developmental relevance, though CD109 has never been investigated in the context of cardiovascular development. We previously identified Cd109 upregulation in murine atrioventricular valves undergoing myxomatous degeneration following a reduction of epicardial-derived cells. Here, we characterize Cd109 expression in the murine cardiovascular system and assess its function during development using in vitro and in vivo approaches. Results: We found that Cd109 is strongly expressed in the endothelium of the coronary vasculature and in endocardial-derived subpopulations in the atrioventricular valves. This expression persists through key stages in cardiovascular development. Western blotting and immunostaining confirm endothelial expression in heart and lung tissues. siRNA-mediated knockdown of CD109 in primary human endothelial cells led to dysregulation of vascular development pathways and decreased tube formation capacity. We generated endothelial-specific Cd109 knockout mice, eliminating Cd109 expression from heart and lung tissues without overt consequences for atrioventricular valve or coronary vascular morphogenesis during heart development. Conclusion: CD109 exhibits a highly dynamic spatiotemporal expression pattern during cardiovascular development, with enriched expression in coronary endothelial cells and endocardial-derived subpopulations in the valves. Despite this striking developmental expression pattern, previously reported human genetic associations with cardiovascular diseases, and endothelial-associated phenotypes following siRNA-mediated CD109 knockdown in a primary human endothelial cell line, endothelial/endocardial-lineage deletion of Cd109 did not produce overt abnormalities in atrioventricular valve or coronary vascular morphogenesis during embryonic development. Collectively, these findings identify CD109 as a useful marker of coronary endothelial and endocardial-derived valve cell populations and suggest that CD109 may function in a context-dependent or modulatory manner rather than as an essential regulator of cardiovascular morphogenesis under normal developmental conditions.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (R01-HL122906)
- National Heart, Lung, and Blood Institute (R01-HL162913)
- National Heart, Lung, and Blood Institute (T32-HL007260)
- American Heart Association (PRE-1014420)
- American Heart Association (PRE-1362464)
- American Heart Association (POST-1369464)
- National Institute of General Medical Sciences (P20-GM103499)
- National Institute of General Medical Sciences (T32-GM132055)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30-AR072582)
This publication has 59 references indexed in Scilit:
- CD109 attenuates TGF-β1 signaling and enhances EGF signaling in SK-MG-1 human glioblastoma cellsBiochemical and Biophysical Research Communications, 2015
- The Role of the Transcription Factor KLF2 in Vascular Development and Disease2014
- Epidermal Hyperplasia and Appendage Abnormalities in Mice Lacking CD109The American Journal of Pathology, 2012
- The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cellsGenesis, 2010
- Cardiogenesis: An Embryological PerspectiveJournal of Cardiovascular Translational Research, 2009
- Valve proteoglycan content and glycosaminoglycan fine structure are unique to microstructure, mechanical load and age: Relevance to an age-specific tissue-engineered heart valveActa Biomaterialia, 2008
- Tie2-Cre Transgenic Mice: A New Model for Endothelial Cell-Lineage Analysis in VivoDevelopmental Biology, 2001
- Characterization of a 150 kDa accessory receptor for TGF‐β1 on keratinocytes: Direct evidence for a GPI anchor and ligand binding of the released formJournal of Cellular Biochemistry, 2001
- The House Mouse1989
- Structural development of endocardial cushionsJournal of Anatomy, 1977